Graystone Company Completes Formulation of its Nano-Delivery of the Fucoidan Longevity Booster
FORT LAUDERDALE, Fla., March 16, 2021 /PRNewswire/ --Graystone Company, Inc. (OTC: GYST) announced today the completion of the formulation of one of its signature products, Fucoidan Longevity Booster, the flagship product for its Immune Support, Anti-Inflammatory & Anti-Aging Product Line.
- FORT LAUDERDALE, Fla., March 16, 2021 /PRNewswire/ --Graystone Company, Inc. (OTC: GYST) announced today the completion of the formulation of one of its signature products, Fucoidan Longevity Booster, the flagship product for its Immune Support, Anti-Inflammatory & Anti-Aging Product Line.
- The Fucoidan Longevity Booster represents the initial product in the expected line of products that will address immune support, anti-inflammatory and anti-aging.
- It has also been shown that fucoidan has the potential to boost important anti-viral, anti-tumor and anti-aging responses.
- Graystone has been committed to delivering the only capsulized nano-formulation that will improve the absorption and effectiveness of the Fucoidan.